B2B SaaS AI image processing tool to monitor drugs at anyscale for state-of-the-art biopharma R&D andManufacturing
The startup has Takeda as their contracted customer, andVertex and Oak Ridge National Laboratory as their pilotstage customers. They have recently become a J&J LABScompany. Johnson & Johnson is the largestpharmaceutical company in the world - and now they are anewly minted member of their scientific community.
A third of JLABS companies secure a contract with J&J, and80% of JLABS companies to date have either exited, gonepublic, or are still thriving. Thanks to J&J, they currentlyhave a pipeline of over 20 companies that boasts >$5MARR.
CloudChipr is a cloud cost management and analytics platform for cloud accounts, it allows to find optimizations and allows automations in 1click saving 30-65% of cloud costs.
CloudChipr graduated from Y combinator. Their current MRR is around $14,000. It has already saved over $50m in cloud costs for their customers.
BlueQubit builds first-in-class quantum software for current and upcoming quantum computers.
BlueQubit is in active negotiations with WellsFargo to implement their solutions at the bank, as well as United States Air Force and theDepartment of Energy (DOE). They recently announced a partnership with Q-CTRL for a joint project, and are working on developing a plugin for PennyLane, integrating their technology with this widely-used quantum machine learning library.
Denovo Sciences is an early-stage drug discovery company.Their data-independent AI platform is based on pure reinforcement learning which excels in tackling targets with scarce data where most of the current AI approaches perform poorly. Their vision centers on creating a target-agnostic AI platform capable of identifying new small-molecule drug candidates with desired properties across a wide range of targets.
Has 3 ongoing projects targeting Influenza, HCV and HBV.They already showcased superior results both in silico and in vitro. Across multiple drug discovery programs, they maintain a remarkable 30% hit rate in each of them. Denovo molecules have already shown successful results in vivo as well.
SleepDoctor is the first digital sleep clinic aiming to provide holistic lifetime sleep care. 1 billion people suffer fromSleep Apnea, 80% of them are undiagnosed. So SD started by providing 10x faster and easier Sleep Apnea diagnostic.
Launched in Paris in September 2021, part of HECIncubator (Station F), revenue is growing 50% every quarter, reached positive unit economics and 75 NPS score. The startup has a $32K ARR and signed a lead investor for EUR1.2m. SD gathered a scientific committee of 3 key opinion leader doctors/scientiests and are about to release a scientific study based on the 60,000questionnaire responses of their patients.
Hosted by Narine Davtian